Antibody Response to Canine Adenovirus-2 Virus Vaccination in Healthy Adult Dogs

Background: Re-vaccination against canine adenovirus (CAV) is performed in ≤3-year-intervals but their necessity is unknown. The study determined anti-CAV antibodies within 28 days of re-vaccination and factors associated with the absence of antibodies and vaccination response. Methods: Ninety-seven...

Full description

Bibliographic Details
Main Authors: Michèle Bergmann, Monika Freisl, Yury Zablotski, Stephanie Speck, Uwe Truyen, Katrin Hartmann
Format: Article
Language:English
Published: MDPI AG 2020-10-01
Series:Viruses
Subjects:
Online Access:https://www.mdpi.com/1999-4915/12/10/1198
_version_ 1797550260847902720
author Michèle Bergmann
Monika Freisl
Yury Zablotski
Stephanie Speck
Uwe Truyen
Katrin Hartmann
author_facet Michèle Bergmann
Monika Freisl
Yury Zablotski
Stephanie Speck
Uwe Truyen
Katrin Hartmann
author_sort Michèle Bergmann
collection DOAJ
description Background: Re-vaccination against canine adenovirus (CAV) is performed in ≤3-year-intervals but their necessity is unknown. The study determined anti-CAV antibodies within 28 days of re-vaccination and factors associated with the absence of antibodies and vaccination response. Methods: Ninety-seven healthy adult dogs (last vaccination ≥12 months) were re-vaccinated with a modified live CAV-2 vaccine. Anti-CAV antibodies were measured before vaccination (day 0), and after re-vaccination (day 7, 28) by virus neutralization. A ≥4-fold titer increase was defined as vaccination response. Fisher’s exact test and multivariate regression analysis were performed to determine factors associated with the absence of antibodies and vaccination response. Results: Totally, 87% of dogs (90/97; 95% CI: 85.61–96.70) had anti-CAV antibodies (≥10) before re-vaccination. Vaccination response was observed in 6% of dogs (6/97; 95% CI: 2.60–13.11). Time since last vaccination (>3–5 years, <i>OR</i> = 9.375, <i>p</i> = 0.020; >5 years, <i>OR</i><i>=</i> 25.000, <i>p</i> = 0.006) was associated with a lack of antibodies. Dogs from urban areas were more likely to respond to vaccination (<i>p</i> = 0.037). Conclusion: Many dogs had anti-CAV pre-vaccination antibodies, even those with an incomplete vaccination series. Most dogs did not respond to re-vaccination. Based on this study, dogs should be re-vaccinated every 3 years or antibodies should be determined.
first_indexed 2024-03-10T15:26:47Z
format Article
id doaj.art-a94338cc820b4626888a3b073dac56e6
institution Directory Open Access Journal
issn 1999-4915
language English
last_indexed 2024-03-10T15:26:47Z
publishDate 2020-10-01
publisher MDPI AG
record_format Article
series Viruses
spelling doaj.art-a94338cc820b4626888a3b073dac56e62023-11-20T17:58:51ZengMDPI AGViruses1999-49152020-10-011210119810.3390/v12101198Antibody Response to Canine Adenovirus-2 Virus Vaccination in Healthy Adult DogsMichèle Bergmann0Monika Freisl1Yury Zablotski2Stephanie Speck3Uwe Truyen4Katrin Hartmann5Clinic of Small Animal Medicine, Centre for Clinical Veterinary Medicine, LMU Munich, Veterinaerstrasse 13, 80539 Munich, GermanyClinic of Small Animal Medicine, Centre for Clinical Veterinary Medicine, LMU Munich, Veterinaerstrasse 13, 80539 Munich, GermanyClinic of Small Animal Medicine, Centre for Clinical Veterinary Medicine, LMU Munich, Veterinaerstrasse 13, 80539 Munich, GermanyInstitute of Animal Hygiene and Veterinary Public Health, University of Leipzig, An den Tierkliniken 1, 04103 Leipzig, GermanyInstitute of Animal Hygiene and Veterinary Public Health, University of Leipzig, An den Tierkliniken 1, 04103 Leipzig, GermanyClinic of Small Animal Medicine, Centre for Clinical Veterinary Medicine, LMU Munich, Veterinaerstrasse 13, 80539 Munich, GermanyBackground: Re-vaccination against canine adenovirus (CAV) is performed in ≤3-year-intervals but their necessity is unknown. The study determined anti-CAV antibodies within 28 days of re-vaccination and factors associated with the absence of antibodies and vaccination response. Methods: Ninety-seven healthy adult dogs (last vaccination ≥12 months) were re-vaccinated with a modified live CAV-2 vaccine. Anti-CAV antibodies were measured before vaccination (day 0), and after re-vaccination (day 7, 28) by virus neutralization. A ≥4-fold titer increase was defined as vaccination response. Fisher’s exact test and multivariate regression analysis were performed to determine factors associated with the absence of antibodies and vaccination response. Results: Totally, 87% of dogs (90/97; 95% CI: 85.61–96.70) had anti-CAV antibodies (≥10) before re-vaccination. Vaccination response was observed in 6% of dogs (6/97; 95% CI: 2.60–13.11). Time since last vaccination (>3–5 years, <i>OR</i> = 9.375, <i>p</i> = 0.020; >5 years, <i>OR</i><i>=</i> 25.000, <i>p</i> = 0.006) was associated with a lack of antibodies. Dogs from urban areas were more likely to respond to vaccination (<i>p</i> = 0.037). Conclusion: Many dogs had anti-CAV pre-vaccination antibodies, even those with an incomplete vaccination series. Most dogs did not respond to re-vaccination. Based on this study, dogs should be re-vaccinated every 3 years or antibodies should be determined.https://www.mdpi.com/1999-4915/12/10/1198CAVvaccineantibody titervirus neutralizationprotectioninfectious canine hepatitis
spellingShingle Michèle Bergmann
Monika Freisl
Yury Zablotski
Stephanie Speck
Uwe Truyen
Katrin Hartmann
Antibody Response to Canine Adenovirus-2 Virus Vaccination in Healthy Adult Dogs
Viruses
CAV
vaccine
antibody titer
virus neutralization
protection
infectious canine hepatitis
title Antibody Response to Canine Adenovirus-2 Virus Vaccination in Healthy Adult Dogs
title_full Antibody Response to Canine Adenovirus-2 Virus Vaccination in Healthy Adult Dogs
title_fullStr Antibody Response to Canine Adenovirus-2 Virus Vaccination in Healthy Adult Dogs
title_full_unstemmed Antibody Response to Canine Adenovirus-2 Virus Vaccination in Healthy Adult Dogs
title_short Antibody Response to Canine Adenovirus-2 Virus Vaccination in Healthy Adult Dogs
title_sort antibody response to canine adenovirus 2 virus vaccination in healthy adult dogs
topic CAV
vaccine
antibody titer
virus neutralization
protection
infectious canine hepatitis
url https://www.mdpi.com/1999-4915/12/10/1198
work_keys_str_mv AT michelebergmann antibodyresponsetocanineadenovirus2virusvaccinationinhealthyadultdogs
AT monikafreisl antibodyresponsetocanineadenovirus2virusvaccinationinhealthyadultdogs
AT yuryzablotski antibodyresponsetocanineadenovirus2virusvaccinationinhealthyadultdogs
AT stephaniespeck antibodyresponsetocanineadenovirus2virusvaccinationinhealthyadultdogs
AT uwetruyen antibodyresponsetocanineadenovirus2virusvaccinationinhealthyadultdogs
AT katrinhartmann antibodyresponsetocanineadenovirus2virusvaccinationinhealthyadultdogs